TrialThe Lancet. Infectious diseases2018

Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.

Menno R Smit et al.PubMed ↗Publisher ↗

No numbers read from the abstract.